onCyt

onCyt Microbiology AG is a Swiss-based biotechnology company, established in 2017, with a focus on smart flow cytometry automation. The company's slogan "Smart Flow Cytometry Automation: Less Effort | More Data | Deeper Insights" reflects its commitment to providing innovative solutions in the field. onCyt Microbiology AG offers hard- and software add-ons for bench-top flow cytometers, aiming to transform them into fully automated online sampling and measurement devices, providing high-quality Swiss engineering to global customers. As an official spin-off of Eawag (Swiss Federal Institute of Aquatic Science and Technology), which is part of the ETH domain, onCyt Microbiology AG benefits from a strong foundation in research and development. The company leverages its expertise in short-term microbial dynamics monitoring, acquired through four years of fundamental research and applied field work, to provide customers with targeted solutions. Moreover, onCyt Microbiology AG places significant emphasis on the intersection of science and engineering, continuously improving its technology and know-how through ongoing scientific research projects, and collaboration with top researchers worldwide. The company's recent Debt Financing investment in August 18, 2022, from the Technology Fund, indicates confidence from investors in the potential of the company's technological solutions and expertise. Overall, onCyt Microbiology AG is well-positioned to create value for its customers by addressing their needs through innovative technological solutions and industry experience.